A-Alpha Bio raises $2.8M for genetically engineered drug discovery platform

The A-Alpha Bio team includes scientist Emily Engelhart, principal scientist David Colby, co-founder and CEO David Younger, co-founder and chief technology officer Randolph Lopez and engineering associate Charles Lin. (A-Alpha Bio Photo)

A Seattle startup that took root at the University of Washington has closed a $2.8 million

This post was originally published on this site

contactedorg

Check out https://contacted.org
Reperio Health raises $6M for at-home medical test subscription service aimed at employers

Reperio Health raises $6M for at-home medical test subscription service aimed at employers

More capital for Pacific Northwest startups: Founders’ Co-op raises $50M fund, its largest yet

More capital for Pacific Northwest startups: Founders’ Co-op raises $50M fund, its largest yet

After struggling to adopt a child, this founder launched a matchmaking platform for other families

After struggling to adopt a child, this founder launched a matchmaking platform for other families

Here’s the first thing President Biden should do to spark entrepreneurship in the US

Here’s the first thing President Biden should do to spark entrepreneurship in the US

Seattle investors talk SPACs; pandemic impact on startups; advice for founders; and more

Seattle investors talk SPACs; pandemic impact on startups; advice for founders; and more

Stoke Space raises $9.1 million to create a new breed of reusable upper-stage rockets

Stoke Space raises $9.1 million to create a new breed of reusable upper-stage rockets

%d bloggers like this: